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Many nuclear hormones have physiological effects that are too
rapid to be explained by changes in gene expression and are often
attributed to unidentified or novel G protein-coupled receptors.
Thyroid hormone is essential for normal human brain development, but the molecular mechanisms responsible for its effects
remain to be identified. Here, we present direct molecular evidence
for potassium channel stimulation in a rat pituitary cell line (GH4C1)
by a nuclear receptor for thyroid hormone, TR␤, acting rapidly at
the plasma membrane through phosphatidylinositol 3-kinase
(PI3K) to slow the deactivation of KCNH2 channels already in the
membrane. Signaling was disrupted by heterologous expression of
TR␤ receptors with mutations in the ligand-binding domain that
are associated with neurological disorders in humans, but not by
mutations that disrupt DNA binding. More importantly, PI3Kdependent signaling was reconstituted in cell-free patches of
membrane from CHO cells by heterologous expression of human
KCNH2 channels and TR␤, but not TR␣, receptors. TR␤ signaling
through PI3K provides a molecular explanation for the essential
role of thyroid hormone in human brain development and adult
lipid metabolism.

The Rac GTPase, like thyroid hormone, is essential for human
neural development (12, 13), but thyroid hormone has not been
reported to stimulate Rac activity. However, Rac is a well known
effector of phosphatidylinositol 3-kinase (PI3K) (14), and other
nuclear receptors have been reported to bind to and stimulate
PI3K (15). Therefore, we postulated that the Rac-dependent
effect of T3 on KCNH2 channel activity was mediated by
activation of PI3K. We demonstrated that KCNH2 stimulation
was blocked by wortmannin (8), an active site inhibitor of PI3K
(16), but we did not identify the receptor for these effects of T3.
Subsequently, PI3K has also been implicated in other rapid
effects of thyroid hormone (17, 18), but the limited temporal and
spatial resolution of the biochemical assays in all these studies
precludes direct evidence for thyroid hormone receptor action in
the cytoplasm. Here, we use the unique temporal and spatial
resolution of the patch-clamp technique (19) in clonal rat
pituitary cells, the original in vitro model system for T3 action
(20), to demonstrate directly that the nongenomic effect of T3 on
KCNH2 channel activity is mediated by a nuclear T3 receptor
acting rapidly at the plasma membrane through PI3K.

neuronal development 兩 phosphatidylinositol 3-kinase 兩 potassium
channels 兩 Rac 兩 KCNH2

Results

T

clamped through gramicidin- or nystatin-perforated patches,
superfusing the cells with T3 rapidly increased the KCNH2
current amplitude by 52 ⫾ 6% (n ⫽ 6) within 3 min (Fig. 1B).
In dialyzed cells, the responses were smaller (Fig. 1C), but, in
both cases, the potency and pharmacology of T3 action on
KCNH2 channels in GH4C1 cells were consistent with its rapid
effect being mediated by a nuclear receptor for T3. Smaller and
slower increases in KCNH2 currents were produced in some cells
by concentrations of T3 as low as 1 pM, but its reverse isomer,
3,3⬘,5⬘-triiodothyronine produced no stimulation at concentrations as high as 100 nM (data not shown). Therefore, we
routinely used 100 nM T3 to rapidly and maximally activate all
T3 receptors. Nevertheless, even at this supramaximal concentration, KCNH2 stimulation by T3 was blocked completely by 3
M 1-850 (Fig. 1C), an antagonist of the nuclear thyroid
hormone receptors in GH4C1 cells (21). We also tested the
involvement of nuclear receptors more directly by transfecting
GH4C1 cells with mutated receptors, which have been shown to
disrupt thyroid hormone signaling (4). Deleting T337 in the C
terminus of TR␤2, which also disrupts neural development in
mice (22), blocked KCNH2 stimulation by T3 in GH4C1 cells
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he thyroid hormone, L-3,5,3⬘triiodothyronine (T3), plays an
essential role in the development and metabolism of many
tissues and organs (1). In particular, mammalian brain development is disrupted when T3 signaling is reduced by inherited
mutations in the T3 receptor gene, THR␤, or when the synthesis
or transport of the T3 prohormone thyroxine (tetraiodothyronine) is reduced by dietary iodine deficiency or environmental
toxicants (2–4). T3 also regulates its own circulating levels
through negative feedback on pituitary thyrotropes, which secrete thyroid stimulating hormone (1). Two genes, THR␣ and
THR␤, encode four alternately spliced ligand-binding zincfinger receptor proteins from the c-erbA family, which mediate
T3 actions on gene expression (5), but specific T3-regulated genes
involved directly in neural development remain to be identified.
Recently, however, attention has shifted to the rapid, nongenomic signaling by T3 (6) and other thyroxine metabolites (7).
For example, we previously reported a Rac-dependent effect
of T3 on voltage-activated potassium channels encoded by the
ether-a-go-go-related gene KCNH2 in a rat pituitary cell line (8).
KCNH2 proteins are voltage-activated potassium channels that
regulate spike frequency in electrically excitable cells, such as the
endocrine cells of the pituitary, through their unique kinetics of
inactivation and recovery (9). Because they inactivate almost
immediately after activation at positive voltages during the peak
of each spike, and then reactivate before closing when the
membrane repolarizes after the spike, they contribute to determining the interspike interval. Thus, increasing KCNH2 activity
decreases excitability and secretion. Rapid effects of thyroid
hormone have been reported previously on other ion channels in
guinea pig cardiac myocytes, but the receptor and its mechanism
of action were not identified (10, 11).

Rapid Stimulation of KCNH2 Channels Involves a Conventional Nuclear
Receptor. In metabolically intact GH4C1 cells that were voltage-

Fig. 1. Rapid stimulation of KCNH2 currents by T3 in GH4C1 cells. (A) Voltage
protocol and resulting currents elicited from a GH4C1 cell. Four current traces
from the same cell are superimposed: control (in blue); perfusion control (in
black); 5 min after application of 100 nM T3 (in red); and 8 min after 5 M E4031
(in green), a selective KCNH2 inhibitor, which completely blocks the T3stimulated current at ⫺120 mV. (B) Time course of changes in KCNH2 current
amplitude measured by voltage protocol repeated at 10-s intervals. (C) Percentage increase in KCNH2 current in the presence of 3 M 1-850, an antagonist of T3 binding to TR␤, or after overnight transfection with mutant TR␤
receptors.

(Fig. 1C). In contrast, the receptor protein, which had been
mutated in the P box (E125G-G126S) to prevent binding to
thyroid receptor-specific DNA response elements (23), had an
insignificant effect on KCNH2 channel stimulation by T3 (Fig.
1C), ruling out nonspecific effects of the transfection protocol.
These results implicate nuclear receptors for thyroid hormone in
KCNH2 stimulation by T3, but they do not identify the mechanism of action at the plasma membrane.

Fig. 2. T3 stimulates individual KCNH2 channels already gating in cellattached patches of plasma membrane on GH4C1 cell voltage-clamped to 0 mV
in high potassium. (A) Voltage protocol repeated at 10-s intervals and 9
representative traces (out of 100) from the same patch of a single KCNH2
channel: 3 traces under control conditions, 3 traces 2 min after addition of 100
nM T3, and 3 traces 2 min after addition of 5 M E4031. (B) Channel open-time
histograms at ⫺60 mV for control and thyroid hormone, T3, treated patches,
and the open probability (PO) is indicated. (C) Summary of changes in seven
such patches plotting percentage of traces, or ‘‘episodes’’ (100 per patch)
where no activity was visible (zero activation) or where activity was sustained
for more than half the duration of the voltage-step (long activation).

T3 Stimulates KCNH2 Activity Through PI3K. We demonstrated pre-

site inhibitor of PI3K (16). Here, we show that TR␤ associates
with the regulatory p85 subunit of PI3K in GH4C1 cells (Fig. 3).
Immunoprecipitation of native TR␤ protein in GH4C1 cells
pulled down native p85 in the absence of hormone (Fig. 3A). We
also transfected CHO cells, which do not express detectable
levels of TR␤ (see below), with recombinant GFP-TR␤ chimeras, which we pulled down by immunoprecipitation of native p85
(Fig. 3B). In both cases, association was reduced by pretreatment
of the cells with 100 nM T3 for 5 min. Nevertheless, T3dependent reduction of the TR␤ association with p85 seems to
increase signaling through PI3K as reflected by reorganization of
the actin cytoskeleton. As illustrated in Fig. 3C, T3 rapidly
stimulates recruitment of Rac to the plasma membrane, actin
reorganization, and lamellipodia formation. All of these effects
are prevented by preincubation with 50 nM wortmannin. Further
evidence for an essential role of PI3K in KCNH2 stimulation by
T3 was obtained by overexpression of the p85 regulatory subunit
of PI3K, which reduced basal KCNH2 currents in GH4C1 cells
from ⫺24.2 ⫾ 3.7 pA兾pF (n ⫽ 4) to ⫺10.9 ⫾ 2.2 pA兾pF (n ⫽
6, Fig. 3D). Conversely stimulating KCNH2 channels in cell-free
patches from GH4C1 cells with 5 M phosphatidylinositol 3,4,5triphosphate (PIP3), the immediate product of PI3K action at the
plasma membrane (14), produced comparable changes in
KCNH2 activity (Fig. 3E) as those observed for T3 on KCNH2
channels in cell-attached patches (Fig. 2). On average, PIP3
increased activity by 61 ⫾ 8.8% (n ⫽ 3) when 1.0 mM ATP and
0.1 mM GTP were present in the solution bathing the former
cytoplasmic side of the membrane, but not when they were
omitted (n ⫽ 3). Thus, PI3K activity is a major determinant of
KCNH2 activity.

viously that the rapid effect of T3 on KCNH2 channels in GH4C1
cells is mediated by a Rac GTPase (8), and we postulated that
T3 stimulated Rac activity through PI3K because the effects of
T3, but not Rac, were blocked by 20 nM wortmannin, an active

Reconstitution of KCNH2 Stimulation by TR␤. Direct molecular
evidence for the involvement of TR␤ in T3 action at the plasma
membrane was obtained by reconstituting KCNH2 channel

T3 Stimulates Activity of Existing Channels Without Trafficking or
Synthesis. In principle, the increase in KCNH2 current illustrated

in Fig. 1 could result from a combination of changes in channel
protein synthesis, insertion into the plasma membrane, or posttranslational modification. However, new synthesis seems unlikely because T3 increases maximal whole-cell currents by
⬇50% within 3 min (Fig. 1), but similar effects on this time scale
have been shown to involve vesicular insertion of nascent
channels in other systems (24, 25). Here, we use the patch-clamp
technique to rule out insertion or trafficking of KCNH2 channels
into the membrane by recording the effect of T3 on individual
KCNH2 channels already gating in the plasma membrane (Fig.
2). In control patches held at 0 mV to activate all of the KCNH2
channels, brief steps to ⫺60 mV, repeated at 3-s intervals on the
same patch of membrane, elicited channel activity in 80% of the
steps. However, in 84% of the steps with activity the channels
returned to the closed state within 75 msec. In contrast, application of T3 to the bath outside the patch pipette produced a
large increase in open probability (Fig. 2B), which resulted from
both a reduction in the percentage of blank traces from 20% to
9% and an increase from 16% to 55% in the percentage of
episodes in which channel activity persisted for the entire
duration of the step (Fig. 2C, n ⫽ 7兾7). Thus, T3 stimulates the
activity of individual channels that are already present in the
plasma membrane.
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stimulation in CHO cells (Fig. 4). When human genes encoding
KCNH2 channels and TR␤2 receptors were coexpressed heterologously in CHO cells, robust, E-4031-sensitive KCNH2 currents were measured with characteristic voltage-dependence
(Fig. 4A). Superfusion with 100 nM T3 increased the KCNH2
current amplitude in CHO cells by 58% (Fig. 4B). In contrast,
coexpression of TR␣1 was unable to reconstitute T3-dependent
stimulation of KCNH2 (Fig. 4B), demonstrating that the effects
of T3 on KCNH2 activity in CHO cells are mediated by TR␤ and
not TR␣ or other unidentified receptors (6, 7). Furthermore,
transfecting CHO cells with TR␤2 alone did not produce any
E-4031-sensitive current (Fig. 4B), ruling out effects of TR␤2
expression on native KCNH2 expression or trafficking in CHO
cells. Finally, we used a unique feature of the patch-clamp
method to obtain direct evidence for TR␤2 action at the plasma
membrane by excising small patches of membrane (2–5 m2 in
area) with its underlying cytoskeletal matrix, and applying T3
directly to the cytoplasmic side of the patch (Fig. 4 C and D).
When the bath solution contained ATP, GTP, and phosphatidylinositol 4,5-bisphosphate (PIP2) to support PIP3 synthesis and
Rac activation, T3 rapidly increased recombinant channel activity in cell-free patches (Fig. 4C). Similar results were obtained
with the mutated TR␤2 E125G-G126S receptor (Fig. 4D), which
does not bind to thyroid-specific response elements in the
nucleus (23). Thus, neither DNA binding nor the nucleus is
required for TR␤2 to stimulate KCNH2 channels in cell-free
patches of membrane.
TR␤ stimulates recombinant KCNH2 channels in cell-free
Storey et al.

Fig. 4. KCNH2 stimulation by T3 is reconstituted in CHO cells with recombinant TR␤2. (A) Voltage-protocol and representative currents from a CHO cell
expressing human KCNH2 and TR␤2. T3 (100 nM, red) increases control current
(black), and 5 M E4031 blocks all of the current at ⫺120 mV. (B) Histograms
comparing current stimulated by T3 in cells expressing TR␤2 or TR␣1. (C)
Voltage protocol and representative single-channel currents elicited from a
cell-free patch taken from a CHO cell expressing KCNH2 and TR␤2. Ensemble
averages of 10 traces before and after 100 nM T3 are displayed. (D) Histograms
showing the percentage increase in ensemble channel activity produced by
100 nM T3 in cells transfected with TR␤2 WT or GS125.

patches from CHO cells through the same signaling cascade we
identified in GH4C1 cells. KCNH2 stimulation was blocked by
inhibition of PI3K with 50 nM wortmannin (Fig. 4B) and also by
removing ATP and GTP from the solution on the cytoplasmic
side of the cell-free patches (data not shown). In the presence of
1.0 mM ATP and 0.1 mM GTP, addition of 5 M PIP3 directly
to the cytoplasmic side of the patch was as effective as T3 at
stimulating KCNH2 activity, rapidly increasing activity by 56 ⫾
10.8% (n ⫽ 5, data not shown). In contrast inositol 1,4,5trisphosphate (IP3), the product of phosphatidylinositol 4,5bisphosphate (PIP2) hydrolysis by phospholipase C, had no effect
on channel activity (n ⫽ 5, data not shown). Therefore, we
conclude that the entire signaling cascade from TR␤ through
PI3K to Rac remains associated with the plasma membrane in
mammalian cells (Fig. 5).
Discussion
The central conclusion of this article is the demonstration that
a nuclear receptor for thyroid hormone, TR␤2, regulates the
activity of KCNH2 potassium channels in the plasma membrane
through a rapid signaling mechanism that does not require the
nucleus or binding to DNA (Fig. 5). This conclusion stands in
contrast to the prevailing view in the field that attributes such
rapid nongenomic actions of nuclear hormones to unidentified
or G protein-coupled receptors (26). Although there have been
previous reports of other nuclear hormone receptor proteins
signaling in the cytoplasm (15, 27), the patch-clamp technique
has allowed us to demonstrate this phenomenon with unusual
temporal and spatial resolution. This effect on KCNH2 channels
in GH4C1 cells is specific for TR␤2 (Fig. 4) and TR␤1 receptors
PNAS 兩 March 28, 2006 兩 vol. 103 兩 no. 13 兩 5199
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Fig. 3.
T3 stimulates KCNH2 channels in GH4C1 cells through PI3K. (A)
Immunoprecipitation of native TR␤ from GH4C1 cell lysates pulls down native
p85, but this association is reduced after 5-min treatment with 100 nM T3. (B)
Immunoprecipitation of native p85 from CHO cell lysates pulls down heterologously expressed GFP-TR␤1, and this association is also reduced after 5 min
in 100 nM T3. (C) Confocal images of GH4C1 cells illustrate the effect of 100 nM
T3 for 15 min on lamellipodia [differential interference contrast microscopy
(DIC)], Rac distribution (green), and F-actin organization (red). Pretreatment
with 50 nM wortmannin prevents the T3-induced changes. (D) Whole-cell
currents elicited by the illustrated family of voltage steps from a control cell
(Upper) and from a cell transfected overnight with p85 (Lower). (E) Single
channel recording of KCNH2 activity in cell-free patch. Control records and
response to 5 M PIP3.

Fig. 5. TR␤ signaling in the nucleus through DNA binding or in the cytoplasm
through PI3K can lead to changes in gene expression. Production of PIP3 also
stimulates cell metabolism through the PIP3-dependent protein kinase (PDK)
and cytoskeleton through guanine exchange factors for the Rac GTPase. The
mechanism of KCNH2 stimulation by Rac is addressed in a separate article (37).

(S.G. and D.L.A., unpublished results) but is not reconstituted
with TR␣ receptors. Gene knockout studies have identified
TR␤2 as the primary receptor responsible for negative feedback
effects of T3 on thyroid-stimulating hormone secretion from
thyrotropes (5), and increasing potassium channel activity is
consonant with this physiological function. TR␤ also regulates
potassium channel activity during development in sensory hair
cells of the mammalian cochlea (3), but the mechanism has not
been addressed. Of more relevance to brain development,
however, mutations in the THR␤ gene that reduce the receptors’
affinity for hormone also produce learning deficits in humans
and mice (28, 29). The most severe mutation in humans, deletion
of T337 (4), blocks KCNH2 stimulation by T3 in GH4C1 cells
(Fig. 1C) and disrupts neural development in mice (22).
We have identified the target of TR␤ action at the plasma
membrane as the phosphatidylinositol 3-kinase, PI3K. Low
concentrations of wortmannin, an active site inhibitor of PI3K
(16), completely prevent T3 action, and the immediate product
of PI3K action, PIP3, recapitulates the effects of T3 on KCNH2
activity. This result is consistent with previous reports implicating phosphoinositides and PIP3-stimulated effectors in KCNH2
regulation (30, 31). We have observed that TR␤ associates with
the p85 regulatory subunit of PI3K in the absence of hormone,
which is consistent with the ability of recombinant mutant
receptors to block signaling by native wild type receptors (Fig. 1).
We postulate that this is a direct interaction because mammalian
isoforms of TR␤, but not TR␣, have a conserved tyrosine residue
in a consensus sequence, pYVXM, for binding to the Src
homology 2 (SH2) domains of p85 (32). We also observe that T3
reduces the association of TR␤ and p85 (Fig. 3). Disinhibition of
unliganded TR␤ action by T3 is the predominant mechanism of
T3 signaling in the nucleus as reflected by the inability of THR␤
gene knockouts to fully phenocopy removal of thyroid hormone
(5). If the inhibitory association with PI3K were stimulated by
tyrosine phosphorylation of TR␤ and relieved by T3 binding, it
would provide a novel and powerful mechanism for regulating
growth responses, which is the classical function of T3 action in
many tissues (1). In this context, it is interesting that selective
TR␤ agonists, which we would predict to stimulate PIP3 production, are as effective at reducing fat accumulation and its
related changes in cholesterol and triglycerides in mice (33) as
the elimination of the lipid phosphatase, SHIP2, which dephosphorylates PIP3 (34).
TR␤ signaling through PI3K is also consistent with our earlier
work demonstrating the requirement for Rac GTPase activity in
the stimulation of KCNH2 channels by T3 (8). Many Rac
exchange factors are recruited and兾or stimulated at the plasma
membrane by PIP3 (14), and T3 rapidly stimulates Rac accumulation at the plasma membrane of GH4C1 cells (Fig. 3). In view
of the essential role of Rac in human neural development (12,
5200 兩 www.pnas.org兾cgi兾doi兾10.1073兾pnas.0600089103

13), the existence of this signaling cascade in neurons would
provide a molecular explanation for some of the most important
physiological roles of TR␤ receptors in brain development and
its susceptibility to disruption by mutation or by environmental
toxicants (2, 4).
Finally, TR␤ signaling through PI3K raises the possibility that
many of the effects of T3 on gene transcription are mediated not
by TR␤ binding to DNA, but by downstream effectors of PI3K
(Fig. 5). For example, deletion of the Tub gene, which is a
T3-regulated, phosphoinositide-binding, transcription factor in
the brain (35), produces many of the same effects on the
developing sensory nervous system as removing thyroid hormone (3). Both the human tubby protein H-tulp-1 (amino acids
296–347) and the human KCNH2 channel protein H-erg-1
(amino acids 12–62) contain homologous phosphoinositidebinding domains, which could target them to a signaling complex
surrounding PI3K at the plasma membrane.
Materials and Methods
Cell Culture and Transfection. Cells were plated onto glass cover-

slips (Deutsche Spiegelglas, Carolina Biological Supply) and
cultured in 5% CO2 in a humidified incubator at 37°C for at least
24 h before transfection or patch-clamp recordings were made.
GH4C1 pituitary cells (ATCC CCL-82.2) were grown in DMEM兾
F-12 with 10% calf serum (HyClone), and CHO fibroblasts were
grown in DMEM with 10% FBS (HyClone). Cells were transfected the day before recording by using Lipofectamine 2000
(Life Technologies, Rockville, MD) in OPTI-MEM (Life Technologies). Baseline currents depend on days in culture and
serum; therefore, every experiment has same-day controls for
comparison.
Plasmids. Human KCNH2 (NM㛭000238) was obtained from
Barry Ganetzky (University of Wisconsin, Madison); mouse
TR␣ (CAA30575) was obtained from Graham R. Williams
(Imperial College, London); human TR␤2 (NP㛭000452) was
obtained from Fred Wondisford (University of Chicago, Chicago); the p85 subunit of PI3K was obtained from James Liao
(Harvard University, Cambridge, MA). The plasmid constructs
were cotransfected at a ratio of 10:1 with a plasmid encoding
GFP (Clontech). Successfully transfected cells were detected
with UV fluorescence 12–36 h later. Control currents were
measured from cells transfected with GFP alone.
Electrophysiological Recordings and Analysis. Potassium currents
were recorded under voltage-clamp with either an EPC9 patchclamp amplifier interface (HEKA Electronics, Lambrecht兾
Pfalz, Germany) or an Axopatch 200 amplifier (Axon Instruments, Foster City, CA). For data acquisition, pulse generation,
and analysis, a computer (Dell, Round Rock, TX) running either
PULSE software (HEKA Electronics) or PCLAMP 9.0 software
(Axon Instruments) was used. Single-channel records were
sampled at 20 KHz and filtered at 1.5 or 2 KHz and idealized with
TAC and TACFIT (Bruxton, Seattle). All experiments were conducted at room temperature (20–24°C). Data are presented as
mean ⫾ SE of n experiments.
The patch pipettes were made from Corning type 7052 glass
(Garner Glass, Claremont, CA) and coated with Sylgard 184
(Dow-Corning) to improve the signal-to-noise ratio and capacitance compensation. To record single-channel currents from
cell-attached patches, the pipette contained 140 mM KCl, 1 mM
CaCl2, 2 mM MgCl2, and 10 mM Hepes, at pH 7.4. To obtain
cell-free recordings, the patch pipette was excised in the insideout configuration into a bath containing 140 mM KCl, 2 mM
MgCl2, 10 mM Hepes, 10 mM glucose, 1 mM dibromoBAPTA,
1 mM ATP, 0.1 mM GTP, and 5 M phosphatidylinositol
4,5-bisphosphate (PIP2). Whole-cell currents were obtained
conventionally from dialyzed cells voltage-clamped through
Storey et al.

Coimmunoprecipitation and Immunoblotting. Cell lysates were pre-

pared from cells that were washed twice with ice-cold PBS and
resuspended in solubilization buffer: 20 mM Tris (pH 7.5), 150
mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 2.5
mM sodium pyrophosphate, 1 mM ␤-glycerolphosphate, 1 mM
sodium vanadate, 1 mM PMSF, and a complete protease inhibitor mixture (mfr). After homogenization by sonication and
centrifugation, the pellet was discarded. Protein concentration in
the supernatant was measured by the Bradford method (Bio-Rad
reagents). For immunoprecipitation, either anti-TR␤ antibody
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(MA1-215; Affinity BioReagents, Golden CO) or anti-p85 antibody (06-497; Upstate, Charlottesville, VA) was added to the
supernatant and incubated overnight at 4°C. Agarose beads
conjugated with either protein G or protein A were added, and
the lysates were incubated further for 1 h at 4°C. Immunoprecipitates were washed four times, and proteins were boiled in
SDS兾PAGE sample buffer and analyzed by SDS兾PAGE. Proteins were transferred to nitrocellulose membranes, blotted with
the antibody indicated, and visualized with enhanced chemiluminescence (ECL, Amersham Pharmacia Bioscience).
Confocal Fluorescence Microscopy. A laser scanning confocal microscope (LSM 510, Carl Zeiss) was used to image cell morphology, Rac distribution, and the actin cytoskeleton through an
oil-immersion Plan-Apo 100 objective (NA1.4). Cells were
treated as described, then fixed with 4% paraformaldehyde for
10 min, washed twice with PBS, blocked with Superblock
(Pierce) for 30 min, and washed twice again. To visualize the
actin cytoskeleton, cells were incubated with Alexa Fluor 568
phalloidin (Molecular Probes) diluted 1:500 for 1 h at 25°C. Cells
were then rinsed twice and kept in PBS, and the actin and tubulin
cytoskeleton was visualized with a 543-nm line of the laser while
collecting phalloidin fluorescence with a 560-nm long pass filter.
For Rac visualization, cells were incubated overnight with
primary anti-Rac antibody 1:250 (Transduction Laboratories,
Lexington, KY and BD Biosciences) and then incubated with
goat anti-mouse secondary antibody (1:1,000) (Molecular
Probes) for 1 h at 25°C. The secondary antibody was excited at
488 nM whereas collection of emission was at 519 nM with a
bandpass 500- to 550-nM filter. All cells were imaged across a
plane as close as possible to where they were attached to the
coverslip. Representative cells are shown in the figures.
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ruptured membrane patches or from metabolically intact cells
voltage-clamped through nystatin- or gramicidin-perforated
patches. In both cases, the solution bathing the cells contained
140 mM KCl, 0.1 mM CaCl2, 2 mM MgCl2, 10 mM Hepes, and
10 mM glucose, at pH 7.4. For dialyzed cells, the pipette
contained 140 mM KCl, 2 mM MgCl2, 10 mM Hepes, 1 mM
dibromoBAPTA, 1 mM ATP, and 0.1 mM GTP. For perforated
patches, the pipettes contained 110 mM K⫹-gluconate, 35 mM
KCl, 2 mM MgCl2, 1 mM CaCl2, and 10 mM Hepes at pH 7.4 and
either 50 g兾ml nystatin, which worked best on GH4C1 cells, or
100 g兾ml gramicidin, which worked best on CHO cells. Both
methods gave similar results although, not unexpectedly, the
response to thyroid hormone was smaller and more transient in
dialyzed cells. However, voltage-clamp is also established more
quickly in dialyzed cells, so it was used in experiments where
many cells were sampled, but all results were confirmed with
cells voltage-clamped through perforated patches.
Current through KCNH2 channels was isolated as a slowly
decaying inward tail current at negative voltages with a voltage
protocol illustrated in the figures. The pulse protocol was run a
minimum of 10 times before the perfusion control and 10 times
before addition of T3 to ensure that the currents were stable.
Successful isolation was confirmed in every experiment with the
class III anti-arrhythmic methane-sulfonanilide E-4031 (10 M;
Biomol, Plymouth Meeting, PA), which selectively blocks
KCNH2 current (36).

